368 related articles for article (PubMed ID: 35884903)
21. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
[TBL] [Abstract][Full Text] [Related]
22. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
23. Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers.
Liang R; Wu C; Liu S; Zhao W
Drug Deliv; 2022 Dec; 29(1):1620-1630. PubMed ID: 35612318
[TBL] [Abstract][Full Text] [Related]
24. Nanocarrier-based drug combination therapy for glioblastoma.
Zhao M; van Straten D; Broekman MLD; Préat V; Schiffelers RM
Theranostics; 2020; 10(3):1355-1372. PubMed ID: 31938069
[TBL] [Abstract][Full Text] [Related]
25. Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy.
Gupta R; Sharma D
ACS Chem Neurosci; 2019 Mar; 10(3):1157-1172. PubMed ID: 30715851
[TBL] [Abstract][Full Text] [Related]
26. Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy.
Sun M; Li Y; Zhang W; Gu X; Wen R; Zhang K; Mao J; Huang C; Zhang X; Nie M; Zhang Z; Qi C; Cai K; Liu G
Acta Biomater; 2023 Aug; 166():552-566. PubMed ID: 37236575
[TBL] [Abstract][Full Text] [Related]
27. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
28. Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO
Uribe-Robles M; Ortiz-Islas E; Rodriguez-Perez E; Valverde FF; Lim T; Martinez-Morales AA
Biomater Adv; 2023 Aug; 151():213442. PubMed ID: 37207587
[TBL] [Abstract][Full Text] [Related]
29. Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.
Lieberman F
F1000Res; 2017; 6():1892. PubMed ID: 29263783
[TBL] [Abstract][Full Text] [Related]
30. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
[TBL] [Abstract][Full Text] [Related]
31. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
32. Recent advancements and theranostics strategies in glioblastoma therapy.
Baddam SR; Kalagara S; Kuna K; Enaganti S
Biomed Mater; 2023 Aug; 18(5):. PubMed ID: 37582381
[TBL] [Abstract][Full Text] [Related]
33. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
34. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
35. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme.
Mekala JR; Adusumilli K; Chamarthy S; Angirekula HSR
Metab Brain Dis; 2023 Aug; 38(6):1801-1829. PubMed ID: 37249862
[TBL] [Abstract][Full Text] [Related]
36. Locoregional Confinement and Major Clinical Benefit of
Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
[TBL] [Abstract][Full Text] [Related]
37. Engineered Aurotherapy for the Multimodal Treatment of Glioblastoma.
Kim HS; Lee DY
Brain Tumor Res Treat; 2022 Oct; 10(4):215-220. PubMed ID: 36347635
[TBL] [Abstract][Full Text] [Related]
38. Lipid-Based Nanocarriers for The Treatment of Glioblastoma.
Iturrioz-Rodríguez N; Bertorelli R; Ciofani G
Adv Nanobiomed Res; 2021 Feb; 1(2):2000054. PubMed ID: 33623931
[TBL] [Abstract][Full Text] [Related]
39. Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma.
Liang T; Song Y; Gu L; Wang Y; Ma W
Int J Gen Med; 2023; 16():4121-4141. PubMed ID: 37720174
[TBL] [Abstract][Full Text] [Related]
40. Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable.
Barzegar Behrooz A; Talaie Z; Syahir A
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
